Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2013-11-12

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1517/13543784.2013.836488PMID 24033127PMCID PMC4422382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine agonists for the treatment of cocaine dependence.

  2015influential reference
• Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.

  2014cited by this paper
• The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study.

  2013cited by this paper
• Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

  2013cited by this paper
• Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.

  2013cited by this paper
• Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions

  2013influential reference
• Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.

  2013cited by this paper
• Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

  2013influential reference
• Antipsychotic drugs in cocaine dependence: a systematic review and meta-analysis.

  2013influential reference
• Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI.

  2013cited by this paper
• Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation

  2012cited by this paper
• Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

  2012influential reference
• Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.

  2012cited by this paper
• Modafinil for the treatment of methamphetamine dependence.

  2012cited by this paper
• Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

  2012cited by this paper
• Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

  2012cited by this paper
• Noradrenergic α1 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial

  2012cited by this paper
• Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial.

  2012cited by this paper
• A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

  2012cited by this paper
• Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.

  2012cited by this paper
• In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

  2012cited by this paper
• Cognitive control and the dopamine D2‐like receptor: a dimensional understanding of addiction

  2012cited by this paper
• The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats

  2012cited by this paper
• Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

  2011cited by this paper
• Dorsolateral Prefrontal Cortex Drives Mesolimbic Dopaminergic Regions to Initiate Motivated Behavior

  2011influential reference
• Decreased dopamine activity predicts relapse in methamphetamine abusers

  2011cited by this paper
• Dopamine agonists for the treatment of cocaine dependence.

  2011cited by this paper
• Oral Methylphenidate Normalizes Cingulate Activity and Decreases Impulsivity in Cocaine Addiction During an Emotionally Salient Cognitive Task

  2011cited by this paper
• How addictive drugs disrupt presynaptic dopamine neurotransmission.

  2011cited by this paper
• Neuropsychological profiling of impulsivity and compulsivity in cocaine dependent individuals

  2011cited by this paper
• The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

  2011cited by this paper
• A Randomized, Placebo‐Controlled Trial of Sustained‐Release Dextroamphetamine for Treatment of Methamphetamine Addiction

  2011cited by this paper
• Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects.

  2011cited by this paper
• Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.

  2010cited by this paper
• The reinforcing, self-reported performance and physiological effects of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users

  2010cited by this paper
• Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.

  2010cited by this paper
• Cocaine Choice in Humans During d-Amphetamine Maintenance

  2010cited by this paper
• Drug harms in the UK: a multicriteria decision analysis.

  2010cited by this paper
• Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.

  2010influential reference
• Neurocircuitry of Addiction

  2010cited by this paper
• Modafinil does not serve as a reinforcer in cocaine abusers.

  2010cited by this paper
• Dopamine and adaptive memory.

  2010cited by this paper
• Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?

  2010cited by this paper
• Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies

  2010influential reference
• Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers

  2010cited by this paper
• A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

  2009cited by this paper
• Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

  2009cited by this paper
• Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

  2009influential reference
• A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion

  2009cited by this paper
• Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.

  2009cited by this paper
• Striatal Dopamine D2/D3 Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity

  2009cited by this paper
• Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.

  2009cited by this paper
• Pharmacotherapy for Cannabis Dependence

  2009cited by this paper
• A review of the clinical pharmacology of methamphetamine.

  2009cited by this paper
• Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

  2009cited by this paper
• Provigil (Modafinil) Plus Cognitive Behavioral Therapy for Methamphetamine Use in HIV+ Gay Men: A Pilot Study

  2009cited by this paper
• Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.

  2009cited by this paper
• Modafinil for the treatment of cocaine dependence.

  2009influential reference
• Self‐administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls

  2009cited by this paper
• A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

  2009cited by this paper
• Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

  2009cited by this paper
• Open-Label Pilot Study of Modafinil for Methamphetamine Dependence

  2009cited by this paper
• The endocannabinoid system in brain reward processes

  2008cited by this paper
• Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys

  2008cited by this paper
• Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.

  2008cited by this paper
• BMC Clinical Pharmacology BioMed Central

  2008cited by this paper
• Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography

  2008cited by this paper
• Smoked Cocaine Self-Administration is Decreased by Modafinil

  2008cited by this paper
• Bupropion for the Treatment of Methamphetamine Dependence

  2008cited by this paper
• Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

  2008cited by this paper
• Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age.

  2008cited by this paper
• Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

  2008cited by this paper
• Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum

  2008cited by this paper
• Bupropion Hydrochloride versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence

  2008cited by this paper
• The Yin and Yang of dopamine release: a new perspective.

  2007influential reference
• Regulation of firing of dopaminergic neurons and control of goal-directed behaviors.

  2007influential reference
• Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

  2007cited by this paper
• Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

  2007influential reference
• Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.

  2007cited by this paper
• Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

  2007cited by this paper
• A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.

  2007influential reference
• Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo

  2007influential reference
• Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain.

  2007cited by this paper
• Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.

  2006cited by this paper
• Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving

  2006cited by this paper
• Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.

  2006cited by this paper
• Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence.

  2006cited by this paper
• Modafinil and Cocaine Interactions

  2006cited by this paper
• Methylphenidate and cocaine: a placebo-controlled drug interaction study.

  2006influential reference
• Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

  2006cited by this paper
• The hippocampal-VTA loop: controlling the entry of information into long-term memory.

  2005cited by this paper
• Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder

  2005influential reference
• The human orbitofrontal cortex: linking reward to hedonic experience

  2005cited by this paper
• A contingency management intervention for adolescent marijuana abuse and conduct problems.

  2005cited by this paper
• Prazosin, an α-1 Adrenergic Antagonist, Reduces Cocaine-Induced Reinstatement of Drug-Seeking

  2005cited by this paper
• A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

  2005cited by this paper
• Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

  2005cited by this paper
• Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking.

  2005cited by this paper
• Safety of intravenous methamphetamine administration during treatment with bupropion

  2005cited by this paper
• Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

  2005influential reference

• Frontal white and gray matter abnormality in gambling disorder: A multimodal MRI study

  2024cites this paper
• Encoding of self-initiated actions in axon terminals of the mesocortical pathway

  2024cites this paper
• Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study

  2023cites this paper
• Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway

  2022cites this paper
• Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography

  2022cites this paper
• Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography

  2021cites this paper
• Drug addiction: from bench to bedside

  2021cites this paper
• COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings.

  2020cites this paper
• Biasing Neurotensin Receptor Signaling to Arrest Psychostimulant Abuse.

  2020cites this paper
• Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors

  2019cites this paper
• Rivastigmine does not alter cocaine-induced subjective effects or self-administration.

  2019cites this paper
• FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration

  2018cites this paper
• Levodopa prevents the reinstatement of cocaine self‐administration in rats via potentiation of dopamine release in the medial prefrontal cortex

  2018cites this paper
• Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self‐administration in rats

  2018cites this paper
• The Clinical Efficacy of Mindfulness-Based Treatments for Alcohol and Drugs Use Disorders: A Meta-Analytic Review of Randomized and Nonrandomized Controlled Trials

  2018cites this paper
• Dopamine and addiction: what have we learned from 40 years of research

  2018cites this paper
• Cocaine Interaction with Dopamine Transporter in the Prefrontal Cortex and Beyond

  2018cites this paper
• Carvedilol does not reduce cocaine use in methadone-maintained cocaine users.

  2017cites this paper
• Unknown face of known drugs – what else can we expect from angiotensin converting enzyme inhibitors?

  2017cites this paper
• Neural mechanisms of affective instability in substance use

  2017cites this paper
• The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.

  2016cites this paper
• Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Social Status in Monkeys : Effects of Social Confrontation on Brain Function and Cocaine Self-Administration

  2016cites this paper
• The role of neuroscience in drug policy: Promises and prospects

  2016cites this paper
• Sex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetine.

  2016cites this paper
• Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study

  2016cites this paper
• Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.

  2016cites this paper
• The &agr;-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals

  2016cites this paper
• Effects of the Trace Amine Associated Receptor 1 Agonist RO5263397 on Abuse-Related Behavioral Indices of Methamphetamine in Rats

  2015cites this paper
• Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys

  2015cites this paper
• Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals

  2015cites this paper
• The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

  2014cites this paper
• Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.

  2014cites this paper
• Issues in the Care and Treatment of HCV/HIV Co-Infection for Key Populations in Resource-Constrained Settings

  2014cites this paper
• Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

  2014cites this paper
• Substance misuse in young people in Ireland - a focus on benzodiazepines

  2014cites this paper
• Stimulants, Wakefulness-promoting Agents, and Nonstimulant Attention Deficit Hyperactivity Disorder Medications

  2013cites this paper